We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.77B
AUM Growth
-$242M
Cap. Flow
-$349M
Cap. Flow %
-12.6%
Top 10 Hldgs %
18.23%
Holding
319
New
33
Increased
50
Reduced
134
Closed
77

Sector Composition

Rank Sector Weight
1 Healthcare 22.04%
2 Technology 19.82%
3 Consumer Discretionary 16.91%
4 Industrials 13.94%
5 Financials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYA
101
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$10.7M 0.39%
+975,301
New +$12.4M
MTH icon
102
Meritage Homes
MTH
$4.95B
$10.5M 0.38%
229,430
-313,382
-58% -$13.6M
APLT
103
DELISTED
Applied Therapeutics
APLT
$10.4M 0.38%
554,279
+38,555
+7% +$832K
KALV
104
DELISTED
KalVista Pharmaceuticals
KALV
$10.2M 0.37%
+397,283
New +$10.4M
NDLS icon
105
Noodles & Co
NDLS
$65.5M
$10.1M 0.37%
122,363
-8,608
-7% -$669K
HASI icon
106
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$9.73M 0.35%
+173,418
New +$10.4M
SUM
107
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$9.03M 0.33%
+327,764
New +$8.24M
PASG icon
108
Passage Bio
PASG
$15.5M
$8.73M 0.32%
24,977
+7,942
+47% +$3.39M
TRIN icon
109
Trinity Capital
TRIN
$1.6B
$8.72M 0.31%
+584,220
New +$8.65M
AMRC icon
110
Ameresco
AMRC
$1.22B
$7.64M 0.28%
+157,170
New +$8.66M
TLYS icon
111
Tilly's
TLYS
$121M
$7.34M 0.26%
648,586
-73,313
-10% -$785K
SNCY
112
DELISTED
Sun Country Airlines
SNCY
$7.31M 0.26%
+213,195
New +$7.23M
HYFM icon
113
Hydrofarm Holdings
HYFM
$3.25M
$7.25M 0.26%
12,028
+4,422
+58% +$3.1M
CCNE icon
114
CNB Financial Corp
CCNE
$1.02B
$6.48M 0.23%
263,177
-98,358
-27% -$2.32M
AAPL icon
115
Apple
AAPL
$4.9T
$6.29M 0.23%
51,461
+3,190
+7% +$409K
HEES
116
DELISTED
H&E Equipment Services
HEES
$5.77M 0.21%
+151,924
New +$4.86M
MSFT icon
117
Microsoft
MSFT
$2.93T
$5.56M 0.2%
23,590
+1
+0% +$232
TWST icon
118
Twist Bioscience
TWST
$5.84B
$5.29M 0.19%
42,678
-92,169
-68% -$14M
MRTX
119
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.47M 0.16%
26,110
-75,936
-74% -$15M
GOSS icon
120
Gossamer Bio
GOSS
$83.2M
$4.18M 0.15%
+451,430
New +$4.55M
AMZN icon
121
Amazon
AMZN
$2.66T
$4.01M 0.14%
25,920
SMG icon
122
ScottsMiracle-Gro
SMG
$4.13B
$3.38M 0.12%
13,784
-340
-2% -$77K
PII icon
123
Polaris
PII
$4.16B
$3.03M 0.11%
22,663
+4,560
+25% +$556K
HZNP
124
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.01M 0.11%
32,684
-17,440
-35% -$1.47M
GOOGL icon
125
Alphabet (Google) Class A
GOOGL
$4.23T
$2.48M 0.09%
24,060

Similar funds

Emerald Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, Emerald Advisers held 319 positions worth $2.77B, down 8% from $3.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $349M in Q1 2021, closing 77 positions and reducing 134 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $35.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $26.1M.

  • Emerald Advisers's largest Q1 2021 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 261,467 shares worth $26.1M.
  • Emerald Advisers added most to AdaptHealth in Q1 2021, an estimated $26.6M increase.
  • Emerald Advisers's biggest Q1 2021 reduction was New Fortress Energy, cutting an estimated $28.3M.
  • Emerald Advisers fully exited Momentive Global Inc. Common Stock in Q1 2021, selling an estimated $35.4M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.77B portfolio in Q1 2021.
  • Emerald Advisers opened 33 new positions and closed 77 in Q1 2021.
  • Emerald Advisers's portfolio value fell 8% quarter-over-quarter to $2.77B.

Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.